Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             82 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 4 Animal models of myelodysplasia: BCL-2 and mutant NRAS-mediated disease progression Padua, R.A.
 2007
 31 Supplement 2 p. S3-
1 p.
 artikel
2 Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1 Qian, Wenbin
 2007
 31 Supplement 2 p. 329-339
11 p.
 artikel
3 Balance of NF-kappaB and p38 MAPK is a determinant of radiosensitivity of the AML-2 and its doxorubicin-resistant cell lines Choi, Cheol-Hee
 2007
 31 Supplement 2 p. 1267-1276
10 p.
 artikel
4 Brefeldin A triggers apoptosis associated with mitochondrial breach and enhances HA14-1- and anti-Fas-mediated cell killing in follicular lymphoma cells Wlodkowic, Donald
 2007
 31 Supplement 2 p. 1687-1700
14 p.
 artikel
5 C008 Clinical and molecular features in patients with juvenile myelomonocytic leukemia-like myeloproliferative disease and Noonan syndrome Kratz, C.P.
 2007
 31 Supplement 2 p. S27-
1 p.
 artikel
6 CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC Perez-Chacon, Gema
 2007
 31 Supplement 2 p. 183-193
11 p.
 artikel
7 Clinical relevance of soluble HLA-I and β2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease Albitar, Maher
 2007
 31 Supplement 2 p. 139-145
7 p.
 artikel
8 Clinical response of myelodysplastic syndromes patients to treatment with coenzyme Q10 Galili, Naomi
 2007
 31 Supplement 2 p. 19-26
8 p.
 artikel
9 C025 Low IPSS score and bone marrow hypocellularity in MDS patients predict haematological responses to anti-thymocyte globulin Lim, Z.Y.
 2007
 31 Supplement 2 p. S36-S37
2 p.
 artikel
10 Coordination of upregulated XBP-1 and downregulated c-myc during myeloma cell differentiation induced by 2-methoxyestradiol Zhou, Xia
 2007
 31 Supplement 2 p. 1259-1265
7 p.
 artikel
11 14 Cytogenetics of myelodysplastic syndromes and detection of del 5q Mufti, G.
 2007
 31 Supplement 2 p. S8-S9
2 p.
 artikel
12 Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis Rohner, Andreas
 2007
 31 Supplement 2 p. 1393-1402
10 p.
 artikel
13 Does p16 ink4a expression increase with the number of cell doublings in normal and malignant lymphocytes? Chebel, Amel
 2007
 31 Supplement 2 p. 1649-1658
10 p.
 artikel
14 Editorial Board 2007
 31 Supplement 2 p. CO2-
1 p.
 artikel
15 Editorial board 2007
 31 Supplement 2 p. i-
1 p.
 artikel
16 Editorial Board 2007
 31 Supplement 2 p. CO2-
1 p.
 artikel
17 E04 Early aggressive chemotherapy seen as the key to advanced Hodgkin lymphoma relapse rates Diehl, V.
 2007
 31 Supplement 2 p. S10-S12
3 p.
 artikel
18 Epigenetic regulation of PRAME gene in chronic myeloid leukemia Roman-Gomez, Jose
 2007
 31 Supplement 2 p. 1521-1528
8 p.
 artikel
19 E07 Stem cell transplantation in ALL: a donor versus no donor comparison in the EORTC ALL-4 study Labar, B.
 2007
 31 Supplement 2 p. S15-S16
2 p.
 artikel
20 Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement Suminoe, Aiko
 2007
 31 Supplement 2 p. 1437-1440
4 p.
 artikel
21 Global cytokine analysis in myeloproliferative disorders Ho, Ching-Liang
 2007
 31 Supplement 2 p. 1389-1392
4 p.
 artikel
22 HA14-1, a small molecule inhibitor of Bcl-2, bypasses chemoresistance in leukaemia cells Oliver, Lisa
 2007
 31 Supplement 2 p. 859-863
5 p.
 artikel
23 28 Increased apoptosis as a mechanism of ineffective erythropoiesis in myelodysplastic syndromes Invernizzi, R.
 2007
 31 Supplement 2 p. S16-S17
2 p.
 artikel
24 Increased responsiveness to TLR2 and TLR4 ligands during dimethylsulfoxide-induced neutrophil-like differentiation of HL-60 myeloid leukemia cells Shuto, Tsuyoshi
 2007
 31 Supplement 2 p. 1721-1728
8 p.
 artikel
25 β2 Integrins are characteristically absent in acute promyelocytic leukemia and rapidly upregulated in vivo upon differentiation with all-trans retinoic acid Wu, Jamie J.
 2007
 31 Supplement 2 p. 49-57
9 p.
 artikel
26 Lack of mitochondrial depolarization by oxidative stress is associated with resistance to buthionine sulfoximine in acute lymphoblastic leukemia cells Goto, Hiroaki
 2007
 31 Supplement 2 p. 1293-1301
9 p.
 artikel
27 Larger than life: Mitochondria and the Bcl-2 family Skommer, Joanna
 2007
 31 Supplement 2 p. 277-286
10 p.
 artikel
28 Limited antitumor-effect associated with toxicity of the experimental cytotoxic drug cyclopentenyl cytosine in NOD/scid mice with acute lymphoblastic leukemia Schimmel, Kirsten J.M.
 2007
 31 Supplement 2 p. 1545-1551
7 p.
 artikel
29 Long-lasting response of therapy-resistant viral warts to treatment with interleukin-2 in a patient with chronic lymphocytic leukemia (CLL) and profound immunodeficiency Hamblin, Terry J.
 2007
 31 Supplement 2 p. 413-414
2 p.
 artikel
30 Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia Molica, Stefano
 2007
 31 Supplement 2 p. 1575-1578
4 p.
 artikel
31 N-Benzyladriamycin-14-valerate (AD 198) cytotoxicty circumvents Bcr-Abl anti-apoptotic signaling in human leukemia cells and also potentiates imatinib cytotoxicity Lothstein, Leonard
 2007
 31 Supplement 2 p. 1085-1095
11 p.
 artikel
32 Nitric oxide induces promyelocytic cell growth arrest and apoptosis through deactivation of Akt pathway Wang, Xiaojian
 2007
 31 Supplement 2 p. 653-660
8 p.
 artikel
33 OP50 Bortezomib in the treatment of multiple myeloma Blade, J.
 2007
 31 Supplement 2 p. S55-S56
2 p.
 artikel
34 OP06 Gene-expression micro-array in AML diagnostics Lowenberg, B.
 2007
 31 Supplement 2 p. S34-
1 p.
 artikel
35 OP33 Hodgkin's lymphoma in Croatia Radman, I.
 2007
 31 Supplement 2 p. S47-S48
2 p.
 artikel
36 OP47 Polycythaemia vera: new approaches, new targets Barbui, T.
 2007
 31 Supplement 2 p. S54-
1 p.
 artikel
37 OP64 Therapeutic approaches in front-line therapy in chronic lymphocytic leukemia Rai, K.R.
 2007
 31 Supplement 2 p. S61-S62
2 p.
 artikel
38 P013 All-transretinoic acid (ATRA) in the treatment of acute promyelocytic leukemia - 15 years of single centre experience Szotkowski, T.
 2007
 31 Supplement 2 p. S70-
1 p.
 artikel
39 P096 AML/MDS with chromosome 5 and 7 abnormalities Stamatoullas, A.
 2007
 31 Supplement 2 p. S91-S92
2 p.
 artikel
40 P027 A new international registry for patients with chronic myeloid leukemia: CAMELIA Faber, E.
 2007
 31 Supplement 2 p. S76-S77
2 p.
 artikel
41 P023 Biological and clinical relevance of matrix metalloproteinases 2 and 9 in acute myeloid leukemias and myelodysplastic syndromes Invernizzi, R.
 2007
 31 Supplement 2 p. S53-
1 p.
 artikel
42 P102 Bone marrow trabnsplantation for acute myeloid leukemia from donor with Gaucher disease followed by enzyme replacement therapy (ERT) Mrsić, M.
 2007
 31 Supplement 2 p. S110-S111
2 p.
 artikel
43 P007 Both HLA DRB1*11 and DRB1*15 are observed more frequently among patients with myelodysplastic syndrome compared to healthy controls Bakanay, S.M.
 2007
 31 Supplement 2 p. S44-
1 p.
 artikel
44 P079 BRAF mutations in juvenile myelomonocytic leukemia de Vries, A.C.H.
 2007
 31 Supplement 2 p. S83-
1 p.
 artikel
45 P113 Chronic myelomonocytic leukemia with monosomy 7 after successful treatment of acute promyelocytic leukemia Jeddi, R.
 2007
 31 Supplement 2 p. S101-
1 p.
 artikel
46 P054 Clinical and morphological characteristics of non-Hodgkin's lymphomas Poddubnaya, I.
 2007
 31 Supplement 2 p. S89-
1 p.
 artikel
47 P065 Coamplification at 8q24 and 11q23 in AML/MDS cell lines MacLeod, R.A.F.
 2007
 31 Supplement 2 p. S75-
1 p.
 artikel
48 P154 Combination of fludarabine and cytarabine as induction treatment of poor prognosis myelodysplastic syndrome (MDS) and secondary acute myeloid leukaemia (sAML): a single centre experience Crotta, A.
 2007
 31 Supplement 2 p. S124-S125
2 p.
 artikel
49 P068 Comparative efficacy analysis of rituximab monotherapy and rituximab plus cyclo-phosphamide, doxorubicin, vincristine and predisone (R-CHOP) regimen in relapsed and refractory non-Hodgkin's lymphoma Lutskaya, T.
 2007
 31 Supplement 2 p. S95-
1 p.
 artikel
50 P099 Efficacy and safety of colistin for the treatment of infections caused by multidrug-resistant isolates of Pseudomonas aeruginosa sensitive to colistin in patients with haematological malignancy Durakovic, N.
 2007
 31 Supplement 2 p. S108-S109
2 p.
 artikel
51 P044 Efficacy of single-agent bortezomib and combination of bortezomib, melphalan, prednison in patients with relapsed and refractory multiple myeloma associated with poor clinical parameters Golenkov, A.
 2007
 31 Supplement 2 p. S84-S85
2 p.
 artikel
52 P082 Enhancement of immune and hematopoietic reconstitution by IL-7 following experimental bone marrow transplantation in a murine model may be mediated by IL-2 and RAG-1 activation Abdul-Hai, A.
 2007
 31 Supplement 2 p. S100-S101
2 p.
 artikel
53 Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606 Mancini, Manuela
 2007
 31 Supplement 2 p. 979-987
9 p.
 artikel
54 P140 Factors predicting for a favorable response among patients with myelodysplastic syndromes treated with erythropoietin ± G-CSF Symeonidis, A.
 2007
 31 Supplement 2 p. S116-S117
2 p.
 artikel
55 P010 Incidence and risk factors of secondary myelodysplastic syndrome/acute leukemia occurrence following peripheral blood progenitor cell autograft: a GITIL (Gruppo Italiano Terapie Innovative Nei Linfomi) survey on 1266 lymphoma patients Zanni, M.
 2007
 31 Supplement 2 p. S45-S46
2 p.
 artikel
56 P048 Increased apoptosis of circulating T cells in myelodysplastic syndromes Satoh, C.
 2007
 31 Supplement 2 p. S66-
1 p.
 artikel
57 P056 International prognostic index, bulky disease, Ki67, bcl-2 and the outcome in newly diagnosed patients with diffuse large B cell lymphoma Perunicic Jovanovic, M.
 2007
 31 Supplement 2 p. S89-S90
2 p.
 artikel
58 P041 Molecular detection and clinics of IgH/MMSET of t(4;14)(4p16;14q32) in multiple myeloma Kusec, R.
 2007
 31 Supplement 2 p. S83-
1 p.
 artikel
59 PO025 Comparison of CFU-GM in patients with chronic myelomonocytic leukemia 1 and 2 (according to WHO classification), with typical myelodysplastic syndromes (MDS) and myeloproliferative diseases (MPD) Wiater, E.
 2007
 31 Supplement 2 p. S141-
1 p.
 artikel
60 PO008 Lactate dehydrogenase in patients with myelodysplastic syndromes Girtovitis, F.
 2007
 31 Supplement 2 p. S132-
1 p.
 artikel
61 PO011 Modelling the cost-effectiveness of Deferasirox (Exjade) in the treatment of iron overloaded myelodysplastic syndrome patients Karnon, J.
 2007
 31 Supplement 2 p. S134-
1 p.
 artikel
62 P024 PKCz involvement in the impaired SDF1a-mediated migration of marrow CD34+ cells from MDS patients Thanopoulou, E.
 2007
 31 Supplement 2 p. S53-S54
2 p.
 artikel
63 P051 Polyclonal CD4+CD25high Foxp3+ regulatory T-cells are significantly increased in high risk myelodysplastic syndromes (MDS) Kordasti, S.
 2007
 31 Supplement 2 p. S68-
1 p.
 artikel
64 P082 Primary myelodysplastic syndromes (MDS) with less than 5% of blasts in bone marrow: study of 147 patients from two centers in São Paulo, Brazil Velloso, E.R.P.
 2007
 31 Supplement 2 p. S84-S85
2 p.
 artikel
65 P127 Prospective cross-sectional analysis of cytopenias and transfusion needs of MDS patients in the USA Sekeres, M.
 2007
 31 Supplement 2 p. S108-S109
2 p.
 artikel
66 P137 Response to erythropoietin (EPO) with or without differentiating treatment with 13-cis-retinoic-acid and dihydroxylated vitamin D3 in myelodysplastic syndromes (MDS) Ferrero, D.
 2007
 31 Supplement 2 p. S114-S115
2 p.
 artikel
67 P010 Treatment of adolescents with acute lymphoblastic leukemia Konja, J.
 2007
 31 Supplement 2 p. S69-
1 p.
 artikel
68 P085 Treatment of steroid refractory graft vs. host disease by intra-arterial infusion Shapira, M.Y.
 2007
 31 Supplement 2 p. S102-
1 p.
 artikel
69 P034 Urinary hepcidin excretion in patients with myelodysplastic syndrome (MDS) and myelofibrosis (MF) Winder, A.
 2007
 31 Supplement 2 p. S59-S60
2 p.
 artikel
70 Quantum dot labeling and tracking of human leukemic, bone marrow and cord blood cells Garon, Edward B.
 2007
 31 Supplement 2 p. 643-651
9 p.
 artikel
71 Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines Berg, Tobias
 2007
 31 Supplement 2 p. 497-506
10 p.
 artikel
72 Solid tumors subsequent to arsenic trioxide treatment for acute promyelocytic leukemia Au, Wing-Yan
 2007
 31 Supplement 2 p. 105-108
4 p.
 artikel
73 Temporary blast reduction after immunoglobulin administration for congenital cytomegalovirus infection masking infant leukemia with cryptic MLL rearrangement Metzler, Markus
 2007
 31 Supplement 2 p. 553-557
5 p.
 artikel
74 The effect of total-ABL, GUS and B2M control genes on BCR-ABL monitoring by real-time RT-PCR Rulcová, Jana
 2007
 31 Supplement 2 p. 483-491
9 p.
 artikel
75 The fundamental contribution of Jan C. Waldenström to the discovery and study of the so-called “Waldenström macroglobulinemia” Ribatti, Domenico
 2007
 31 Supplement 2 p. 435-438
4 p.
 artikel
76 The spectrum of myelodysplastic syndromes post-solid organ transplantation: A single institutional experience Menes, M.
 2007
 31 Supplement 2 p. 59-65
7 p.
 artikel
77 TPL-2 MEK kinase is not targeted by mutation in diffuse large B cell lymphoma and myeloid leukemia Shirali, Sima
 2007
 31 Supplement 2 p. 1604-1607
4 p.
 artikel
78 t(8;14)(q24;q32) in two patients with CD10-negative primary thyroid diffuse large B-cell lymphoma Niitsu, Nozomi
 2007
 31 Supplement 2 p. 707-711
5 p.
 artikel
79 Unexpected protection from infection by two booster hepatitis B virus vaccination in children with acute lymphoblastic leukemia Yetgin, Sevgi
 2007
 31 Supplement 2 p. 493-496
4 p.
 artikel
80 2 What is WHO in myelodysplastic syndromes? Bennett, J.M.
 2007
 31 Supplement 2 p. S1-
1 p.
 artikel
81 30 Which myelodysplastic syndromes patients are candidates for treatment with hematopoietic growth factors? Fenaux, P.
 2007
 31 Supplement 2 p. S18-S19
2 p.
 artikel
82 WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders Michiels, Jan Jacques
 2007
 31 Supplement 2 p. 1031-1038
8 p.
 artikel
                             82 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland